This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.86% per year. These returns cover a period from January 1, 1988 through September 7, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
healthcare: Archive
OPRX Trades at a Discount to Industry: How to Approach the Stock Now?
by Shreya Majumder
OptimizeRx trades at a steep discount to peers, but strong AI-driven growth, rising cash flow and DAAP traction look encouraging.
OMCLPositive Net Change OPRXNegative Net Change VEEVPositive Net Change DOCSPositive Net Change
artificial-intelligence business-services computers healthcare medical medical-devices pharmaceuticals robotics saas tech-stocks
UnitedHealth vs. Elevance: Which Healthcare Stock Has More Upside?
by Rajshree Sipani
UNH's integrated Optum engine and earnings stability give it an edge over ELV as shifting costs and policy changes reshape managed care dynamics.
UNHPositive Net Change ELVPositive Net Change
artificial-intelligence healthcare hmo hospitals insurance insurance-premium medical smart-health
UnitedHealth Jumps on CMS' MA Rate Boost: How to Position Now
by Kaibalya Pravo Dey
CMS boosts 2027 Medicare Advantage rates, sparking a sharp UNH rally despite lingering cost pressures.
UNHPositive Net Change HUMPositive Net Change CNCPositive Net Change
healthcare hmo insurance medical
The Longevity Economy: Why Healthcare REITs Are in Focus
by Urmimala Biswas
Ventas highlights how aging demographics are boosting healthcare REIT demand, with senior housing occupancy growth and limited supply supporting long-term growth.
VTRPositive Net Change OHIPositive Net Change CTREPositive Net Change WELLPositive Net Change
finance healthcare housing medical medical-devices real-estate
The Upside Debate: UnitedHealth's Consistency vs. Centene's Comeback
by Kaibalya Pravo Dey
UNH's steady execution and diversified model face off against CNC's turnaround bid as cost pressures and policy shifts reshape upside potential.
UNHPositive Net Change CNCPositive Net Change
healthcare hmo insurance medical
Tempus AI's Diagnostics and Data Arms Drive Long-Term Growth Story
by Urmimala Biswas
Tempus AI's dual-engine model drives $1.27B revenues, with Diagnostics dominating and Data monetization accelerating growth and pricing leverage.
IRTCPositive Net Change TXGPositive Net Change TEMPositive Net Change
artificial-intelligence healthcare medical medical-devices
Healthcare Jobs Drop, UnitedHealth Stock Slips: Opportunity or Risk?
by Kaibalya Pravo Dey
UNH faces rising medical costs, regulatory probes and a healthcare hiring slump while shares keep falling, leaving investors weighing risk or opportunity.
UNHPositive Net Change MOHPositive Net Change CNCPositive Net Change
healthcare hmo insurance medical
Best Health & Fitness Stocks to Buy Now for Strong Growth
by Nilanjan Choudhury
GRMN, HLF and AMWL stand out in a booming wellness market as wearables, nutrition products and telehealth platforms reshape how consumers pursue healthier lives.
AMZNPositive Net Change AAPLNegative Net Change GRMNNegative Net Change HLFPositive Net Change AMWLPositive Net Change
biotechnology biotechs healthcare medical-devices thematic
UnitedHealth vs. Humana: Which Healthcare Stock Has More Upside Now?
by Rajshree Sipani
UNH's scale and diversified model are likely to offer stronger upside than HUM as rising medical costs test managed care margins.
UNHPositive Net Change HUMPositive Net Change
artificial-intelligence healthcare hmo insurance insurance-premium medical smart-health
UnitedHealth's Q4 Beat Can't Stop the Slide: Should You Let Go Now?
by Kaibalya Pravo Dey
UNH beats Q4 EPS, but the stock plunges 21.5% as medical costs spiked, margins sank, and Medicare reimbursement risk clouded its outlook.
UNHPositive Net Change MOHPositive Net Change CNCPositive Net Change
earnings-report earnings-surprise healthcare hmo insurance insurance-premium medical